
Andrew Huntley
Managing Partner
伦敦, 胡志明市
Andrew Huntley is a Managing Partner of BDA. Having joined the co-founders in 1998, he established and oversaw BDA’s early Asian offices including Singapore, Shanghai and Hong Kong, subsequently co-managed BDA’s New York office from 2002 to 2005, and managed its London office from 2005 to 2018.
He now travels widely in Asia and Europe from his base in Ho Chi Minh City and oversees BDA’s global Healthcare & Life Sciences sector. Mr. Huntley has advised clients on transactions across Asia as well as in Europe and North America, including both blue chip corporate clients such as Arkema, Celestica, Clariant, Edenred, Henkel, Jardine Matheson, Johnson Matthey, Laird Group, Rexel, Sumitomo Chemical, SunGard, ThomsonReuters, Tata Motors and Weir Group as well as financial sponsors such as Actis, Ardian, Bregal Capital, EQT, LDC, Investcorp, Mekong Capital, Nova Capital, Prudential, Segulah, Seera and STIC. Before BDA, Mr. Huntley worked for the Jardine Matheson Group in HK, China, Taiwan and Vietnam. He acted as the Group Representative in Vietnam and had executive responsibility for Group businesses there and in Taiwan. Mr. Huntley was educated at Oxford University (MA Hons, Chinese). He is fluent in Mandarin and conversant in Vietnamese.
Recent transactions
Acquired by Solenis
2022
Agreed to divest East Syracuse, New York facility to LOTTE Corporation
2022
Divested PEARL iZUMi to United Sports Brands and Bregal Partners
2022
Debt and equity restructuring
2022
出售给Novo Holdings
2022
Investment from The Riverside Company
2021
Acquired by Koura
2021
Acquired by MicroPort
2021
Divested 100% to EagleTree Capital
2021
Divested 100% to by Escalent
2021
拟出售给迈瑞医疗
2021
Raised Series B round from ABC World Asia
2021
出售尼奥斯给松柏投资
2020
Divested Escientia Life Sciences to Deccan Fine Chemicals
2020
Divested significant stake in Kehua Bio-Engineering to Gree Real Estate
2020
Divested majority stake to The Longreach Group
2019
Divested Model Solution to Hankook Tire
2018
Divested The Ritedose Corporation to AGIC and Humanwell
2017
Divested its 48.08% equity stake in Netas to ZTE
2017
Majority recapitalized by Galen Partners
2017